Loading
Castor
Castor is a global provider of decentralized and hybrid clinical trial solutions, offering a user-friendly eClinical platform that simplifies medical research. Founded in 2012 by Derk Arts, the company is headquartered in Amsterdam, Netherlands, with additional offices in Hoboken and New York City. Castor operates primarily as a Software-as-a-Service (SaaS) and Professional Services provider in the HealthTech and Life Sciences sectors. The company's eClinical platform supports the entire clinical trial lifecycle, enabling rapid deployment and efficient data management. Key features include decentralized clinical trials, electronic data capture, and tools for collecting patient-reported outcomes. Castor emphasizes human-centered design, ensuring a seamless experience for both researchers and patients. With a strong focus on security and data reusability, Castor is committed to democratizing research and enhancing the quality of clinical data. The company has secured $65 million in funding, positioning itself as a vital partner in the clinical research landscape.
Funding
Every round, secondary, debt facility or acquisition involving Castor that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$51M